Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis.
about
Clinical Manifestations and Myositis-Specific Autoantibodies Associated with Physical Dysfunction after Treatment in Polymyositis and Dermatomyositis: An Observational Study of Physical Dysfunction with Myositis in JapanPUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndrome.Ovoid Palatal Patch in Dermatomyositis: A Novel Finding Associated With Anti-TIF1γ (p155) Antibodies.Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patients.Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.The Clinical Features of Myositis-Associated Autoantibodies: a Review.Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.Serological subsets of juvenile idiopathic inflammatory myopathies--an update.Expression of the autoantigen TRIM33/TIF1γ in skin and muscle of patients with dermatomyositis is upregulated, together with markers of cellular stress.Integrated classification of inflammatory myopathies.Autoimmune Myopathies.Dermatomyositis and Immune-Mediated Necrotizing Myopathies: A Window on Autoimmunity and Cancer.Factors Associated With Clinical Remission of Skin Disease in Dermatomyositis.Idiopathic inflammatory myopathies overlapping with systemic diseases.Triple cancers concurrently detected in a case of antitranscriptional intermediary factor-1γ antibody-positive dermatomyositis.A chronic recurrent disease course of dermatomyositis is associated with autoantibodies against transcriptional intermediary factor 1-γ.Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.Bench to bedside review of myositis autoantibodies.
P2860
Q36559044-E0F40BDB-3B40-41BD-A070-4F677B5807E9Q36788809-DAAFD956-4B8B-4F54-9617-3FC321E8431CQ37577904-D422C8D2-1475-4CA8-A775-1556706BBA66Q37696163-2C33C1CF-3009-440C-9850-C4226D6C8343Q38534871-C96FFEC7-D0A6-431E-8027-E1340906FF19Q38603422-6D23B2C2-4640-40A9-BB03-5A3EA70E342DQ38646384-1257C7D8-B441-4BFA-A43C-035E8848A58BQ38664251-69443661-0446-445F-BCEB-C8DA0365848CQ38714316-7939542E-3B10-4798-81AC-6BF7B4591B2EQ39027323-9D4C5F93-1878-42A5-8891-EC527DCE5375Q39030495-C3524B75-6D26-41B8-BA4F-8461B584E1E7Q41485219-25B23029-5920-4E27-A4A2-B8662EEF9D69Q46134512-9B591E2C-CD22-441F-A437-0C43DF226F00Q47401892-73A1DF69-9EA1-4A2F-9AC2-D216ECFFD867Q48105769-82168DDE-3652-46E2-8BD7-93D63F064D4BQ48109917-1577F071-2566-4D29-8899-1F365074455CQ51280183-E48A7FA8-4C60-4CAE-9544-043EFC309EA0Q55425108-C7168CD9-55E0-4FC0-8D12-26A3727345B3
P2860
Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Distinctive cutaneous and syst ...... n adults with dermatomyositis.
@ast
Distinctive cutaneous and syst ...... n adults with dermatomyositis.
@en
type
label
Distinctive cutaneous and syst ...... n adults with dermatomyositis.
@ast
Distinctive cutaneous and syst ...... n adults with dermatomyositis.
@en
prefLabel
Distinctive cutaneous and syst ...... n adults with dermatomyositis.
@ast
Distinctive cutaneous and syst ...... n adults with dermatomyositis.
@en
P2093
P2860
P1476
Distinctive cutaneous and syst ...... n adults with dermatomyositis.
@en
P2093
David F Fiorentino
Livia Casciola-Rosen
Lorinda Chung
Shufeng Li
P2860
P304
P356
10.1016/J.JAAD.2014.12.009
P407
P577
2015-01-14T00:00:00Z